A concise and scalable synthesis of high enantiopurity (-)-d-erythro- sphingosine using peptidyl thiol ester-boronic acid cross-coupling

Organic Letters

Volumn 9, Issue 16, 2007, Pages 2993-2995

  Yang, Hao ^a   Liebeskind, Lanny S ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORONIC ACID DERIVATIVE; COPPER; DRUG DERIVATIVE; ERYTHRO (2R,3S) SPHINGOSINE; ERYTHRO-(2R,3S)-SPHINGOSINE; ESTER; PALLADIUM; SERINE; SPHINGOSINE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

BORONIC ACIDS; CATALYSIS; COPPER; ESTERS; MOLECULAR STRUCTURE; PALLADIUM; SERINE; SPHINGOSINE; STEREOISOMERISM; SULFHYDRYL COMPOUNDS;

EID: 34547944244     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol070991m     Document Type: Article

References (27)

1. (a) Milstien, S.; Spiegel, S. Cancer Cell 2006, 9, 148-150.
2. (b) Ogretmen, B.; Hannun, Y. A. Nat. Rev. Cancer 2004, 4, 604-616.
3. (c) Smith, W. L.; Merrill, A. H., Jr. J. Biol. Chem. 2002, 277, 25841-25842.
4. (d) Spiegel, S.; Milstien, S. Nature Rev. Mol. Cell Biol. 2003, 4, 397-407.
5. Philippe, M.; Garson, J. C.; Gilard, P.; Hocquaux, M.; Hussler, G.; Leroy, F.; Mahieu, C.; Semeria, D.; Vanlerberghe, G. Int. J. Cosmet. Sci. 1995, 17, 133-146.
6. For recent syntheses see: (a) Merino, P.; Jimenez, P.; Tejero, T. J. Org. Chem. 2006, 71, 4685-4688.
7. (b) Rai, A. N.; Basu, A. Org. Lett. 2004, 6, 2861-2863.
8. (c) Lu, X.; Cseh, S.; Byun, H.-S.; Tigyi, G.; Bittman, R. J. Org. Chem. 2003, 68, 7046-7050.
9. Garner, P.; Park, J. M. J. Org. Chem. 1987, 52, 2361-2364.
10. Dondoni, A.; Perrone, D. Org. Synth. 2000, 77, 64-77.
11. (a) Koskinen, A. M. P.; Krische, M. J. Synlett 1990, 665-666.
12. (b) Koskinen, P. M.; Koskinen, M. P. Method Enzymol. 1999, 311, 458-479.
13. (c) Chung, S.-K.; Lee, J.-M. Tetrahedron: Asymmetry 1999, 10, 1441-1444.
14. For other examples of sphingosine syntheses by cross-metathesis see: (a) Chang, C.-W.; Chen, Y.-N.; Adak, A. K.; Lin, K.-H.; Tzou, D.-L. M.; Lin, C.-C. Tetrahedron 2007, 63, 4310-4318.
15. (b) Yamamoto, T.; Hasegawa, H.; Hakogi, T.; Katsumura, S. Org. Lett. 2006, 8, 5569-5572.
16. (c) Torssell, S.; Somfai, P. Org. Biomol. Chem. 2004, 2, 1643.
17. Yang, H.; Li, H.; Wittenberg, R.; Egi, M.; Huang, W.; Liebeskind, L. S. J. Am. Chem. Soc. 2007, 129, 1132-1140.
18. Brown, H. C.; Bhat, N. G.; Somayaji, V. Organometallics 1983, 2, 1311-1316.
19. Szabo, L.; Li, Y.; Polt, R. Tetrahedron Lett. 1991, 32, 585-588.
20. Chen, K. M.; Hardtmann, G.; Prasad, K.; Repic, O.; Shapiro, M. J. Tetrahedron Lett. 1987, 28, 155-158.
21. 1H NMR.
22. Hoffman, R. V.; Najib, M.; Cervantes-Lee, F. J. Org. Chem. 2002, 67, 1045-1056.
23. LC-MS showed 4 isomers of 11 with the same mass weight based on the synthetic route with a racemic mixture of 9.
24. (-)-D-erythro-Sphingosine was characterized as its triacetate derivative. See the Supporting Information.
25. (a) Szulc, Z. M.; Hannun, Y. A.; Bielawska, A. Tetrahedron Lett. 2000, 41, 7821-7824.
26. (b) Murakami, T.; Furusawa, K.; Tamai, T.; Yoshikaib, K.; Nishikawa, M. Bioorg. Med. Chem. Lett. 2005, 15, 1115-1119.
27. Yang, H.; Liebeskind, L. S. U.S. Prov. Patent Appl. 60/842,624, September 6, 2006.